Skip to content

The Impact of Clozapine and Other Antipsychotic Drugs on the Occurrence of HAP in Hospitalized Schizophrenia Patients: A Prospective, Multicenter Cohort Study

The Impact of Clozapine and Other Antipsychotic Drugs on the Occurrence of HAP in Hospitalized Schizophrenia Patients: A Prospective, Multicenter Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112733
Enrollment
Unknown
Registered
2025-11-19
Start date
2025-02-24
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hospital-acquired pneumonia among schizophrenia patients

Interventions

Clozapine group:None
Non-clozapine group:None

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. First hospitalization during the study period; 2. Length of hospital stay>= 48 hours; 3. Age >= 18 years; 4. Diagnosed with schizophrenia (ICD-10 code F20) or schizoaffective disorder (ICD-10 code F25) and treated with antipsychotic medication; 5. Voluntarily participated in the study and provided signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Incomplete case documentation; 2. Admission diagnosis includes community-acquired pneumonia; 3. Pregnant or lactating; 4. Currently participating in a similar study.

Design outcomes

Primary

MeasureTime frame
Hospital-Acquired Pneumonia;Antipsychotic Medication Treatment Status;

Secondary

MeasureTime frame
Sociodemographic characteristics and lifestyle (including age, sex, residence, etc.);Positive and Negative Syndrome Scale;Clinical Global Impression Scale;Brief Psychiatric Rating Scale;Activities of Daily Living Scale;Somatic Comorbidities;Nutritional Risk Screening Score;Immunosuppressant Usage;Hepatic Enzyme Inhibitor Usage;Smoking Status;Alcohol Consumption ;Electroconvulsive Therapy;Inpatient Environment ;Complete Blood Count;Liver Function Tests;Pulmonary Imaging Findings;

Countries

China

Contacts

Public ContactHan Jingjing

Renmin Hospital of Wuhan University

894069719@qq.com+86 189 8616 3468

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026